Deprecated: Hook custom_css_loaded is deprecated since version jetpack-13.5! Use WordPress Custom CSS instead. Jetpack no longer supports Custom CSS. Read the WordPress.org documentation to learn how to apply custom styles to your site: https://wordpress.org/documentation/article/styles-overview/#applying-custom-css in /customers/6/e/3/senatormedical.se/httpd.www/wp-includes/functions.php on line 6085 Surgery or Electrochemotherapy? – Senator Medical AB

 

A randomised control trial comparing electrochemotherapy and surgery with five year follow up for primary basal cell carcinoma

Basal cell carcinoma (BCC) are the commonest cutaneous malignancy and incidence continues to increase. There is a need to expand the therapeutic toolbox to increase options for patients that are unsuitable for or unwilling to undergo the current therapies.

Electrochemotherapy (ECT) is a technique where cells are temporarily permeabilized after exposure to a brief pulsed electrical field and combined with low dose chemotherapeutics to ablate malignancies. It is a simple technique causing minimal damage to the surrounding healthy tissue and has the potential to avoid the need for complex reconstruction. ECT is an established treatment for skin metastases but its role as a primary treatment modality is not demonstrated.

Comparative study between ElectroChemotherapy Vs Surgery

A prospective randomised control trial evaluating ECT against the gold standard of treatment, Surgery, was performed for patients with primary BCC and patients followed for 5 years. All lesions treated with ECT (n = 69) responded although 8/69 (12%) needed a second treatment to ensure a complete response. All surgical lesions (n = 48) showed histological evidence of complete excision with 2/48 (4%) undergoing a second excision. At 5 years, in the surgical arm there was no evidence of recurrence in 39/40 (97.5%) lesions with 1/40 (2.5%) confirmed recurrence. In the ECT arm there was no evidence of recurrence in 42/48 lesions (87.5%). There was 5 confirmed recurrences. These groups show statistical equivalence in this non inferiority study design (p = 0.33).

ECT is an effective and durable treatment option for primary BCC and should be considered as part of the armamentarium of options available.

Reference:

Read the original article on Elsevier Journal



Leave a Reply

This website uses cookies and asks your personal data to enhance your browsing experience.